Journal Home > Volume 19 , Issue 4
BACKGROUND

Catheter ablation for atrial fibrillation (AF) is commonly performed worldwide. However, the clinical characteristics of hospitalized patients with AF and national trends in catheter ablation at tertiary hospitals in China remain unreported.

METHODS

This study used the Chinese national database (Hospital Quality Monitoring System) from 2013 to 2016, which is a mandatory database that collects the front page of patients’ medical records for hospital accreditation, to describe the clinical characteristics of patients with AF as an overall cohort and as subgroups divided by catheter ablation and sex.

RESULTS

Of 597,919 AF patients first admitted, 57,983 patients underwent catheter ablation [56,384 cases (97.2%) of radiofrequency ablation and 1599 cases (2.8%) of cryoablation] at 746 tertiary hospitals. Nearly 10% of patients hospitalized with AF at tertiary hospitals in China underwent catheter ablation, and the percentage of patients undergoing catheter ablation was on the rise between 2013 and 2016, and the number of cases increased by 2.5 times. Compared with AF patients who did not undergo catheter ablation, those who did were younger, more frequently male, and had fewer baseline comorbidities. Although the overall CHA2DS2VASc score revealed over half of the patients were high-risk, patients who underwent catheter ablation were mostly low-risk (71.2% of males and 59.1% of females). Considering in-hospital adverse events, the overall pericardial tamponade and all-cause death incidences were 0.2% (0.6% in the ablation group) and 1.2% (0.1% in the ablation group), respectively; both of which were higher in females than males.

CONCLUSIONS

In this study, AF patients who underwent catheter ablation were relatively young, had a low thrombosis risk, and had few comorbidities and adverse events. Females were older and experienced more complications than males.


menu
Abstract
Full text
Outline
About this article

Trends and sex differences in atrial fibrillation hospitalization and catheter ablation at tertiary hospitals in China from 2013 to 2016

Show Author's information Kang LI1,*Fang-Fang FAN1,*Peng-Fei SUN1Jie JIANG1Jing ZHOU1Ying SHI2Hai-Bo WANG3Jian-Ping LI1Yan ZHANG1( )Yong HUO1( )
Department of Cardiology, Peking University First Hospital, Beijing, China
Scientific Project Department, China Standard Medical Information Research Centre, Shenzhen, China
Clinical Trial Unit, the First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China

*The authors contributed equally to this manuscript

Abstract

BACKGROUND

Catheter ablation for atrial fibrillation (AF) is commonly performed worldwide. However, the clinical characteristics of hospitalized patients with AF and national trends in catheter ablation at tertiary hospitals in China remain unreported.

METHODS

This study used the Chinese national database (Hospital Quality Monitoring System) from 2013 to 2016, which is a mandatory database that collects the front page of patients’ medical records for hospital accreditation, to describe the clinical characteristics of patients with AF as an overall cohort and as subgroups divided by catheter ablation and sex.

RESULTS

Of 597,919 AF patients first admitted, 57,983 patients underwent catheter ablation [56,384 cases (97.2%) of radiofrequency ablation and 1599 cases (2.8%) of cryoablation] at 746 tertiary hospitals. Nearly 10% of patients hospitalized with AF at tertiary hospitals in China underwent catheter ablation, and the percentage of patients undergoing catheter ablation was on the rise between 2013 and 2016, and the number of cases increased by 2.5 times. Compared with AF patients who did not undergo catheter ablation, those who did were younger, more frequently male, and had fewer baseline comorbidities. Although the overall CHA2DS2VASc score revealed over half of the patients were high-risk, patients who underwent catheter ablation were mostly low-risk (71.2% of males and 59.1% of females). Considering in-hospital adverse events, the overall pericardial tamponade and all-cause death incidences were 0.2% (0.6% in the ablation group) and 1.2% (0.1% in the ablation group), respectively; both of which were higher in females than males.

CONCLUSIONS

In this study, AF patients who underwent catheter ablation were relatively young, had a low thrombosis risk, and had few comorbidities and adverse events. Females were older and experienced more complications than males.

References(30)

[1]

Zoni-Berisso M, Lercari F, Carazza T, et al. Epidemiology of atrial fibrillation: European perspective. Clin Epidemiol 2014; 6: 213−220.

[2]

Wang Z, Chen Z, Wang X, et al. The disease burden of atrial fibrillation in China from a national cross-sectional survey. Am J Cardiol 2018; 122: 793−798.

[3]

Tse HF, Wang YJ, Ahmed Ai-Abdullah M, et al. Stroke prevention in atrial fibrillation: an Asian perspective. Heart Rhythm 2013; 10: 1082−1088.

[4]

January CT, Wann LS, Calkins H, et al. 2019 AHA/ACC/HRS focused update of the 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association task force on clinical practice guidelines and the Heart Rhythm Society. J Am Coll Cardiol 2019; 74: 104−132.

[5]

Hindricks G, Potpara T, Dagres N, et al. 2020 ESC guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): the task force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Eur Heart J 2021; 42: 373−498.

[6]

Chao TF, Joung B, Takahashi Y, et al. 2021 focused update consensus guidelines of the Asia Pacific Heart Rhythm Society on stroke prevention in atrial fibrillation: executive summary. Thromb Haemost 2022; 122: 20−47.

[7]

Elayi CS, Darrat Y, Suffredini JM, et al. Sex differences in complications of catheter ablation for atrial fibrillation: results on 85,977 patients. J Interv Card Electrophysiol 2018; 53: 333−339.

[8]

Tripathi B, Arora S, Kumar V, et al. Temporal trends of in-hospital complications associated with catheter ablation of atrial fibrillation in the United States: an update from Nationwide Inpatient Sample database (2011-2014). J Cardiovasc Electrophysiol 2018; 29: 715−724.

[9]

Yang C, Wang H, Zhao X, et al. CKD in China: evolving spectrum and public health implications. Am J Kidney Dis 2020; 76: 258−264.

[10]

Sun P, Li J, Fang W, et al. Effectiveness of chest pain centre accreditation on the management of acute coronary syndrome: a retrospective study using a national database. BMJ Qual Saf 2021; 30: 867−875.

[11]

Zhang L, Li J, Li N, et al. Trends in cause-related comorbidities in hospitalized patients with secondary hypertension in China from 2013 to 2016: a retrospective analysis of hospital quality monitoring system data. J Hypertens 2021; 39: 2015−2021.

[12]

Calkins H, Hindricks G, Cappato R, et al. 2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation. Heart Rhythm 2017; 14: e275−e444.

[13]

Du X, Patel A, Anderson CS, et al. Epidemiology of cardiovascular disease in China and opportunities for improvement: JACC international. J Am Coll Cardiol 2019; 73: 3135−3147.

[14]

Ghanbari H, Başer K, Jongnarangsin K, et al. Mortality and cerebrovascular events after radiofrequency catheter ablation of atrial fibrillation. Heart Rhythm 2014; 11: 1503−1511.

[15]

Boriani G, Vitolo M, Lane DA, et al. Beyond the 2020 guidelines on atrial fibrillation of the European society of cardiology. Eur J Intern Med 2021; 86: 1−11.

[16]

Shinohara T, Takahashi N. Guidelines for atrial fibrillation treatment to avoid stroke should be established for each region/ethnicity. Circ J 2019; 83: 2413−2415.

[17]
Cappato R. Implementation of guidelines on atrial fibrillation management in the global arena: so many actors on stage! Eur J Intern Med 2021; 86: 22–24.
DOI
[18]

Cappato R, Calkins H, Chen SA, et al. Prevalence and causes of fatal outcome in catheter ablation of atrial fibrillation. J Am Coll Cardiol 2009; 53: 1798−1803.

[19]

Abdur Rehman K, Wazni OM, Barakat AF, et al. Life-threatening complications of atrial fibrillation ablation: 16-year experience in a large prospective tertiary care cohort. JACC Clin Electrophysiol 2019; 5: 284−291.

[20]

Wu L, Narasimhan B, Ho KS, et al. Safety and complications of catheter ablation for atrial fibrillation: predictors of complications from an updated analysis the National Inpatient Database. J Cardiovasc Electrophysiol 2021; 32: 1024−1034.

[21]

Kaiser DW, Fan J, Schmitt S, et al. Gender differences in clinical outcomes after catheter ablation of atrial fibrillation. JACC Clin Electrophysiol 2016; 2: 703−710.

[22]

Patel D, Mohanty P, Di Biase L, et al. Outcomes and complications of catheter ablation for atrial fibrillation in females. Heart Rhythm 2010; 7: 167−172.

[23]

Hosseini SM, Rozen G, Saleh A, et al. Catheter ablation for cardiac arrhythmias: utilization and in-hospital complications, 2000 to 2013. JACC Clin Electrophysiol 2017; 3: 1240−1248.

[24]

Beck H, Curtis AB. Sex differences in outcomes of ablation of atrial fibrillation. J Atr Fibrillation 2014; 6: 1024.

[25]

Holmqvist F, Simon D, Steinberg BA, et al. Catheter ablation of atrial fibrillation in U. S. community practice: results from Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF). J Am Heart Assoc 2015; 4: e001901.

[26]

Piccini JP, Simon DN, Steinberg BA, et al. Differences in clinical and functional outcomes of atrial fibrillation in women and men: two-year results from the ORBIT-AF registry. JAMA Cardiol 2016; 1: 282−291.

[27]

Patel D, Mohanty P, Di Biase L, et al. Outcomes and complications of catheter ablation for atrial fibrillation in females. Heart Rhythm 2010; 7: 167−172.

[28]

Kuck KH, Brugada J, Fürnkranz A, et al. Impact of female sex on clinical outcomes in the FIRE AND ICE trial of catheter ablation for atrial fibrillation. Circ Arrhythm Electrophysiol 2018; 11: e006204.

[29]

Santangeli P, di Biase L, Pelargonio G, et al. Outcome of invasive electrophysiological procedures and gender: are males and females the same? J Cardiovasc Electrophysiol 2011; 22: 605−612.

[30]

Huang G, Parikh PB, Malhotra A, et al. Relation of body mass index and gender to left atrial size and atrial fibrillation. Am J Cardiol 2017; 120: 218−222.

Publication history
Copyright
Acknowledgements
Rights and permissions

Publication history

Published: 28 April 2022
Issue date: April 2022

Copyright

© 2022 JGC All rights reserved

Acknowledgements

ACKNOWLEDGMENTS

This study was supported by the China-WHO Biennial Collaborative Projects 2016–2017 (No.2016/648722–0). All authors had no conflicts of interest to disclose. The authors thank all China Standard Medical Information Research Centre members for their help and support throughout the study.

Rights and permissions

Return